Federal grants to Lectenz Bio, Inc.
Lectenz Bio, Inc. in Athens, Georgia received $5.9 million in federal grants from fiscal 2021 to 2025, across 6 awards. Its largest program was Research Infrastructure Programs, with $3.1 million. In fiscal 2025 it was awarded $1.3 million.
From USAspending.gov award records, updated October 31, 2026.
- Grants, FY 2021 to 2025$5.9 million
- Awards6
- Awarded in FY 2025$1.3 million
- Largest award$2.3 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 3 | $1.2 million |
| FY 2022 | 1 | $37,199 |
| FY 2023 | 2 | $1.3 million |
| FY 2024 | 2 | $2.0 million |
| FY 2025 | 2 | $1.3 million |
Programs that fund Lectenz Bio, Inc.
| Program | Awards | Amount |
|---|---|---|
| Research Infrastructure Programs | 2 | $3.1 million |
| Biomedical Research and Research Training | 4 | $2.8 million |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 6 | $5.9 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Engineered pan-specific reagents for n-glycan detection and enrichment - project summary glycans play crucial roles in nearly every aspect of biological processes, and their distinct properties make them appealing as disease biomarker targets. However, due to their highly branched and variably linke | Research Infrastructure Programs | July 20, 2023 | $2.3 million |
| A new approach to monitoring glycosylation during glycoprotein production - project summary during the production of therapeutic biologicals, glycosylation has been identified as a critical quality attribute (CQA) that must be carefully monitored to ensure that the desired protein stability, immunog | Biomedical Research and Research Training | September 15, 2023 | $2.0 million |
| Pan-specific tools and reagents for the enrichment of sialo-glycans | Research Infrastructure Programs | March 17, 2021 | $777,775 |
| Innovative glycan-specific reagents to accelerate the detection of disease biomarkers - project summary glycans have several distinct properties that make them excellent targets for disease biomarkers. Firstly, because the structures of cell surface glycans are determined by a complex enzymatic path | Biomedical Research and Research Training | July 18, 2025 | $313,827 |
| Development of a suite of high-specificity fucose binding reagents | Biomedical Research and Research Training | February 26, 2021 | $225,000 |
| Novel reagents for monitoring sulfation patterns in heparin and heparan sulfate | Biomedical Research and Research Training | February 15, 2021 | $222,795 |
Questions people ask
How much federal grant money does Lectenz Bio, Inc. get?
$5.9 million in 6 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Lectenz Bio, Inc. the most?
The Department of Health and Human Services, with $5.9 million in 6 awards.
What is Lectenz Bio, Inc.'s largest federal grant?
$2.3 million under Research Infrastructure Programs, with its first action in the period on July 20, 2023. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Lectenz Bio, Inc.?
Its largest are Research Infrastructure Programs and Biomedical Research and Research Training.
Other grant recipients in Athens
- University of Georgia Research Foundation, Inc.
- University of Georgia
- Housing Authority of the City of Athens Georgia
- Soil & Water Conservation Commission Geo
- Clarke County School District
- Athens Tech College
- Athens-Clark Government
- Advantage Behavioral Health Systems
Largest federal grant recipients in Georgia · Federal grants in Georgia